Free Trial

Perspective Therapeutics (CATX) News Today

Perspective Therapeutics logo
$6.16 -0.62 (-9.14%)
(As of 11/20/2024 ET)
Perspective Therapeutics (CATX) Receives a Buy from RBC Capital
FY2024 EPS Estimates for CATX Lifted by Cantor Fitzgerald
Perspective Therapeutics, Inc. stock logo
CATX FY2024 EPS Estimate Boosted by Cantor Fitzgerald
Perspective Therapeutics, Inc. (NYSE:CATX - Free Report) - Stock analysts at Cantor Fitzgerald upped their FY2024 earnings per share estimates for shares of Perspective Therapeutics in a note issued to investors on Wednesday, November 13th. Cantor Fitzgerald analyst L. Chen now expects that the c
Perspective Therapeutics, Inc. stock logo
WealthPlan Investment Management LLC Invests $4.53 Million in Perspective Therapeutics, Inc. (NYSE:CATX)
WealthPlan Investment Management LLC bought a new position in shares of Perspective Therapeutics, Inc. (NYSE:CATX - Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 339,292 shares of the company's stock, va
Perspective Therapeutics, Inc. stock logo
Perspective Therapeutics, Inc. (NYSE:CATX) Receives Consensus Recommendation of "Buy" from Analysts
Perspective Therapeutics, Inc. (NYSE:CATX - Get Free Report) has been assigned a consensus rating of "Buy" from the ten ratings firms that are covering the company, MarketBeat reports. Ten research analysts have rated the stock with a buy recommendation. The average 12 month price target among bro
Perspective Therapeutics, Inc. stock logo
Hills Bank & Trust Co Invests $13.72 Million in Perspective Therapeutics, Inc. (NYSE:CATX)
Hills Bank & Trust Co bought a new position in shares of Perspective Therapeutics, Inc. (NYSE:CATX - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 1,027,830 shares of the company's stock,
Perspective Therapeutics initiated with a Buy at UBS
Wedbush Sticks to Its Buy Rating for Perspective Therapeutics (CATX)
Perspective Therapeutics, Inc. stock logo
Nicholson Wealth Management Group LLC Acquires New Holdings in Perspective Therapeutics, Inc. (NYSE:CATX)
Nicholson Wealth Management Group LLC purchased a new position in Perspective Therapeutics, Inc. (NYSE:CATX - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,602,283 s
Perspective Therapeutics, Inc. stock logo
Perspective Therapeutics (NYSE:CATX) Shares Gap Up - Here's What Happened
Perspective Therapeutics (NYSE:CATX) Shares Gap Up - Here's Why
Perspective Therapeutics, Inc. stock logo
Perspective Therapeutics (NYSE:CATX) Receives "Outperform" Rating from Wedbush
Wedbush reissued an "outperform" rating and issued a $20.00 price target on shares of Perspective Therapeutics in a report on Thursday.
Perspective Therapeutics, Inc. stock logo
UBS Group Begins Coverage on Perspective Therapeutics (NYSE:CATX)
UBS Group began coverage on shares of Perspective Therapeutics in a research note on Thursday. They issued a "buy" rating and a $20.00 price objective for the company.
Perspective Therapeutics (CATX) Gets a Buy from Truist Financial
Perspective Therapeutics, Inc. stock logo
Perspective Therapeutics (NYSE:CATX) Trading Up 4.9% - Should You Buy?
Perspective Therapeutics (NYSE:CATX) Shares Up 4.9% - Here's What Happened
Perspective Therapeutics, Inc. stock logo
Perspective Therapeutics (NYSE:CATX) Sees Large Volume Increase - What's Next?
Perspective Therapeutics (NYSE:CATX) Sees Unusually-High Trading Volume - Here's Why
Perspective Therapeutics, Inc. stock logo
Perspective Therapeutics (NYSE:CATX) Shares Gap Down - Should You Sell?
Perspective Therapeutics (NYSE:CATX) Shares Gap Down - Here's Why
Perspective Therapeutics, Inc. stock logo
Perspective Therapeutics, Inc. (NYSE:CATX) Given Consensus Rating of "Buy" by Brokerages
Shares of Perspective Therapeutics, Inc. (NYSE:CATX - Get Free Report) have earned a consensus rating of "Buy" from the nine ratings firms that are covering the company, MarketBeat.com reports. Eight analysts have rated the stock with a buy recommendation and one has given a strong buy recommendat
Perspective Therapeutics, Inc. stock logo
Perspective Therapeutics (NYSE:CATX) Shares Down 3.6% - What's Next?
Perspective Therapeutics (NYSE:CATX) Stock Price Down 3.6% - Here's What Happened
Perspective Therapeutics, Inc. stock logo
Point72 Asset Management L.P. Sells 13,250,683 Shares of Perspective Therapeutics, Inc. (NYSE:CATX)
Point72 Asset Management L.P. cut its stake in Perspective Therapeutics, Inc. (NYSE:CATX - Free Report) by 98.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 202,572 shares of the company's stock after se
Perspective Therapeutics, Inc. stock logo
Perspective Therapeutics (NYSE:CATX) Upgraded by Wedbush to Strong-Buy
Wedbush upgraded Perspective Therapeutics to a "strong-buy" rating in a research report on Monday.
Get Perspective Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CATX and its competitors with MarketBeat's FREE daily newsletter.

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Claim your FREE 2024 Gold Guide

CATX Media Mentions By Week

CATX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CATX
News Sentiment

0.78

0.46

Average
Medical
News Sentiment

CATX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CATX Articles
This Week

8

3

CATX Articles
Average Week

Get Perspective Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CATX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:CATX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners